Digital Immunohistochemistry Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 644.23 Million |
| Market Size (2029) | USD 884.69 Million |
| CAGR (2024 - 2029) | 6.55 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Digital Immunohistochemistry Market Analysis
The Digital Immunohistochemistry Market size is estimated at USD 644.23 million in 2024, and is expected to reach USD 884.69 million by 2029, at a CAGR of 6.55% during the forecast period (2024-2029).
Digital immunohistochemistry (IHC) is one of the most promising applications brought by new generation image analysis. Technological advancements in imaging, including high-resolution scanners and digital lab platforms, have enhanced the capabilities of digital IHC for analyzing tissue samples at a microscopic level more effectively. These advancements improve the accuracy and efficiency of diagnosis.
For instance, a study published in the Journal of Pathology Informatics in June 2022, reveals that automated estrogen receptor immunohistochemistry digital image analysis demonstrates excellent concordance with pathologist's scores and accurately discriminates estrogen receptor positive cases. Furthermore, integrating automated biomarker digital imaging analysis in immunohistochemistry into a busy clinical digital workflow is feasible and also saves time and labor for pathologists.
Moreover, manufacturers push the boundaries of innovation to meet the growing demand for digital immunohistochemistry is also a factor that drives the demand for digital immunohistochemistry. For instance, in June 2023, Aiosyn's QC solution, AiosynQC, has expanded its compatibility to include immunohistochemistry (IHC) slides, alongside its existing support for hematoxylin and eosin (H&E) slides. This enhancement not only broadens the utility of AiosynQC but also empowers laboratories heavily dependent on IHC staining to optimize their operations even further.
Thus, the validation and seamless incorporation of automated digital image analysis for immunohistochemistry into clinical workflows, coupled with companies' initiatives to transition traditional immunohistochemistry into the digital realm through the introduction of supportive digital products, are poised to propel market growth. However, complexity of integration coupled with high initial cost to set up digital lab is expected to hamper the market studied.
Digital Immunohistochemistry Market Trends
Hospital and Diagnostic Laboratories Segment is Expected to Dominant The Digital Immunohistochemistry Market during the Forecast Period
The hospital segment plays a pivotal role in the growth and adoption of the digital immunohistochemistry market. Digital immunohistochemistry refers to the digitization of traditional immunohistochemistry processes, where high-resolution images of pathology slides are captured and analyzed using specialized software. Laboratories, as critical nodes in healthcare systems, are uniquely positioned to benefit from this transition by enhancing diagnostic accuracy, efficiency, and collaboration.
The hospital and reference laboratories segment within the digital immunohistochemistry market is experiencing growth due to significant healthcare investments, increasing prevalence of cancer cases, which require effective treatment, and laboratories adopting digital platforms to perform immunohistochemistry over the study period.
The hospital segment in the digital immunohistochemistry market is experiencing growth, supported by substantial expenditure within the healthcare system. For instance, according to the Federal Ministry of Health, in 2023, total expenditure by the Statutory Health Insurance (SHI) system in Germany reached EUR 30.3 billion (USD 33.0 billion) in 2022, up from EUR 30.1 billion (USD 32.8 billion) in 2021. This significant investment underscores the robust funding allocated to hospitals and the adoption of advanced diagnostic tools like digital pathology, thereby driving the digital immunohistochemistry market growth within the hospital segment to enhancing diagnostic capabilities.
Moreover, the increasing adoption of AI-driven digital pathology integration into laboratory workflows and hospitals is expected to boost the segment’s growth. For instance, in April 2024, six NHS hospitals in the north of England, part of the West Yorkshire Association of Acute Trusts (WYAAT), adopted the National Pathology Imaging Co-operative (NPIC) digital pathology system. This system, designed for high-definition scanning and secure digital sharing of slides, marks a significant milestone in hospital-based digital laboratory.
Therefore, the hospital and reference laboratories segment is expected to grow significantly due to the increasing adoption of innovative digital pathology solutions, which will drive the segment’s growth in the digital immunohistochemistrymarket.
North america is Expected to Hold a Significant Share in the Market Over the Forecast Period
North America is expected to witness considerable growth over the forecast period. Factors such as the growing prevalence of chronic diseases that require quick and effective diagnosis, technological advancements, adoption of digital pathology laboratories, and the presence of significant players in this region are expected to contribute to the growth of the digital immunohistochemistry market in the North American region.
For instance, in September 2024, the University Health Network (UHN) in Toronto expanded its digital laboratory capabilities to partner hospitals in northern Ontario, showcasing the system's impact on real-time diagnosis and decision-making. As more hospitals adopt digital pathology systems, the future of healthcare diagnostics will continue to evolve, improving patient outcomes and transforming hospital workflows. Thus, the adoption of digital pathology systems can streamline laboratory workflows, reduce turnaround times, and enhance operational efficiency. This optimization drives the adoption of digital immunohistochemistry solutions as part of a comprehensive digital pathology infrastructure.
Furthermore, the increasing company focus on adopting various vital strategies such as collaborations, partnerships, agreements, and product launches is expected to increase the demand and the adoption of digital immunohistochemistry product in the market. This is anticipated to fuel market growth. For instance, In March 2023, Paige integrated Mindpeak's AI algorithms, designed for immunohistochemical biomarker quantification, into its platform.
Thus, the rising adoption of digital pathology in hospitals, along with strategic partnerships formed by the players are expected to accelerate the need for robust digital laboratory solutions in the United States, and this trend is expected to accelerate market growth over the forecast period.
Digital Immunohistochemistry Industry Overview
The digital immunohistochemistry market is moderately competitive and consists of a few major players. Companies, like Danaher Corporation, Aiosyn, Vision Pharma A/S, Path AI, F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc. Parhelia Biosciences and TissueGnostics GmbH among others hold substantial market shares in the digital Immunohistochemistry market.
New product developments, acquisitions, collaborations, and regional expansions are some of the key strategic initiatives undertaken by major players to maintain stability in the market.
Digital Immunohistochemistry Market Leaders
-
Danaher Corporation
-
Vision Pharma A/S
-
F. Hoffmann-La Roche Ltd
-
Agilent Technologies, Inc.
-
TissueGnostics GmbH
*Disclaimer: Major Players sorted in no particular order
Digital Immunohistochemistry Market News
- May 2024: PathAI has unveiled two innovative AI products; PathExplore Immuno-Oncology Profiling (IOP) and Immunohistochemistry Explore1. These products be used to support biomarker discovery and the development of companion diagnostics.
- June 2022: Karkinos Healthcare has launched India's inaugural oncology laboratory, offering a full suite of cancer diagnostic services via digital platforms. This center serves as a comprehensive hub for cancer diagnostics, encompassing histopathology, Immunohistochemistry (IHC), and Fluorescence in situ hybridization (FISH), among other services.
Digital Immunohistochemistry Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Advancements in Imaging Technology
4.2.2 Rising Demand for Disease Diagnosis More Effectively
4.3 Market Restraints
4.3.1 Complexity of Integration Coupled With High Initial Cost to Set Up Digital Lab
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
5.1 By Product Type
5.1.1 Equipment
5.1.1.1 Slide Staining System
5.1.1.2 Scanner
5.1.1.3 Tissue Processing System
5.1.1.4 Others
5.1.2 Software
5.2 By Application
5.2.1 Disease Diagnostic
5.2.2 Drug Discovery & Research
5.3 By End User
5.3.1 Pharmaceutical and Biotechnoloy Companies
5.3.2 Hospitals & Diagnostic Laboratories
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Danaher Corporation
6.1.2 Aiosyn
6.1.3 Vision Pharma A/S
6.1.4 Path AI
6.1.5 F. Hoffmann-La Roche Ltd
6.1.6 Agilent Technologies, Inc.
6.1.7 Parhelia Biosciences
6.1.8 TissueGnostics GmbH
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Digital Immunohistochemistry Industry Segmentation
As per the scope of the report, digital immunohistochemistry refers to a technique that uses digital tools to improve the quality of immunohistochemistry staining and to help pathologists interpret the results. Digital immunohistochemistry enables the storage of digital images in electronic formats, facilitating easy access, retrieval, and sharing of data among pathologists, researchers, and clinicians.
The digital immunohistochemistry is segmented into product, application, and end user. By product market is segmented into equipment and software. In terms of application, the market is segmented into disease diagnosis and drug discovery & research. By end user, the market is segmented into pharmaceutical & biotechnology companies, hospital and diagnostic laboratories, and others. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD) for the above segments.
| By Product Type | ||||||
| ||||||
| Software |
| By Application | |
| Disease Diagnostic | |
| Drug Discovery & Research |
| By End User | |
| Pharmaceutical and Biotechnoloy Companies | |
| Hospitals & Diagnostic Laboratories | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Digital Immunohistochemistry Market Research FAQs
How big is the Digital Immunohistochemistry Market?
The Digital Immunohistochemistry Market size is expected to reach USD 644.23 million in 2024 and grow at a CAGR of 6.55% to reach USD 884.69 million by 2029.
What is the current Digital Immunohistochemistry Market size?
In 2024, the Digital Immunohistochemistry Market size is expected to reach USD 644.23 million.
Who are the key players in Digital Immunohistochemistry Market?
Danaher Corporation, Vision Pharma A/S, F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc. and TissueGnostics GmbH are the major companies operating in the Digital Immunohistochemistry Market.
Which is the fastest growing region in Digital Immunohistochemistry Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Digital Immunohistochemistry Market?
In 2024, the North America accounts for the largest market share in Digital Immunohistochemistry Market.
What years does this Digital Immunohistochemistry Market cover, and what was the market size in 2023?
In 2023, the Digital Immunohistochemistry Market size was estimated at USD 602.03 million. The report covers the Digital Immunohistochemistry Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Digital Immunohistochemistry Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Digital Immunohistochemistry Industry Report
Statistics for the 2024 Digital Immunohistochemistry market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Digital Immunohistochemistry analysis includes a market forecast outlook for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
